Tuesday, October 25, 2011: 2:30 PM
Grand Ballroom AB (Hyatt Regency Chicago)
| Category Reference |
| BEC | Behavioral Economics |
ESP | Applied Health Economics, Services, and Policy Research |
| DEC | Decision Psychology and Shared Decision Making |
MET | Quantitative Methods and Theoretical Developments |
* Candidate for the Lee B. Lusted Student Prize Competition
Poster Board #
1
(DEC)
VIRTUAL EXPERIENCE AS A PROXY FOR NUMERACY IN PROBABILITY COMMUNICATION
Mark D. Horowitz, MS1, Robert B. Allen, Ph.D.2 and Prudence W. Dalrymple, Ph.D.2, (1)Drexel University, Ambler, PA, (2)Drexel University, Philadelphia, PA
2
(DEC)
AN IN-DEPTH REVIEW OF THE HISTORY AND USE OF THE CONTROL PREFERENCE SCALE
Suzanne K. Linder, Ph.D., André W. Hite Jr., B.S., M.P.H., Zubin N. Segal, M.P.H. and Robert J. Volk, PhD, The University of Texas MD Anderson Cancer Center, Houston, TX
3
(DEC)
VALUES AND PREFERENCES IMPORTANT IN CONTRACEPTIVE DECISION MAKING: A QUALITATIVE STUDY
Tessa Madden, MD, MPH1, Gina Secura, PhD, MPH2, Ragini Maddipati, MSW2 and Jeffrey Peipert, MD, PhD2, (1)Washington University School of Medicine, Saint Louis, MO, (2)Washington University in Saint Louis, Saint Louis, MO
5
(DEC)
USAGE AND CHARACTERISTICS OF PATIENT SATISFACTION WEBSITES
Jennifer Schneider Chafen, M.D., M.S.1, Jason Mann, M.D., PhD.2, Cathie Markow, MBA, RN2, Anastasia Toles, M.D., MPH2 and Dena M. Bravata, MD, MS1, (1)Stanford University, Stanford, CA, (2)Castlight Health, San Francisco, CA
6
(DEC)
AWARENESS OF DYING; IT NEEDS WORDS
M.E. Lokker, RN, MSc1, L. van Zuylen, MD, PhD1, L. Veerbeek, PhD2, C.C.D. van der Rijt, MD, PhD, Prof3 and A. van der Heide, MD, PhD3, (1)Erasmus Medical Centre, Rotterdam, Netherlands, (2)Comprehensive Cancer Centre, Leiden, Netherlands, (3)Erasmus MC University Medical Centre, Rotterdam, Netherlands
8
(DEC)
ASSESSMENT OF PARENTAL HEALTH STATE PREFERENCES FOR DIAGNOSTIC EVALUATION AND CLINICAL OUTCOMES IN URINARY TRACT INFECTION IN YOUNG CHILDREN
Galina Lipton, MD1, Eve Wittenberg, PhD, MPP2, Jamie Nichols3, Mariah Rich, BS4 and Marvin Harper, MD1, (1)Childrens Hospital Boston, Harvard Medical School, Boston, MA, (2)Heller School for Social Policy and Mgmt., Waltham, MA, (3)Northeastern University, Boston, MA, (4)Harvard School of Public Health, Boston, MA
9
(DEC)
NAMING THE DOWNSIDES OF SURGERY: RACIAL AND GENDER VARIATIONS IN PERCEIVED HAZARDS OF SURGICAL CARE
Mark D. Neuman, M.D., M.Sc., Jason H. Karlawish, M.D., Chidimma Osigwe, BA, Said Ibrahim, M.D., M.P.H. and Fran A. Barg, Ph.D., University of Pennsylvania, Philadelphia, PA
10
(DEC)
“THE HARDEST DECISION I EVER HAD”: PARENT DECISION MAKING ABOUT TNF-α INHIBITOR TREATMENT
Ellen A. Lipstein, MD, MPH, Daniel J. Lovell, MD, MPH, Lee A. Denson, MD, David W. Moser, MD, Shehzad A. Saeed, MD, Cassandra M. Dodds and Maria T. Britto, MD, MPH, Cincinnati Children's Hospital Medical Center, Cincinnati, OH
11
(DEC)
EXACKTE2: EXPLORING DYADIC RELATIONSHIPS WITHIN PATIENT-PHYSICIAN CONSULTATIONS USING THE ACTOR-PARTNER INTERDEPENDENCE MODEL
France Légaré, MD, PhD1, Stéphane Turcotte, MSc2, Hubert Robitaille, PhD3, Moira Stewart, MD, PhD4, Dominick Frosch, PhD5, Jeremy Grimshaw, MBChB, PhD, FRCGP6, Michel Labrecque, MD, PhD7, Mathieu Ouimet, Ph.D8, Michel Rousseau, Ph.D8, Dawn Stacey, PhD9, Trudy van der Weijden10 and Glyn Elwyn, MD, PhD11, (1)CHUQ Research Center-Hospital St-François d'Assise, Knowledge Transfer and Health Technology Assessment, Quebec, QC, Canada, (2)CHUQ Research Center-Hospital St-François d'Assise, Knowledge Transfer and Health Technology Assessment, Québec, QC, Canada, (3)Research center of Centre hospitalier universitaire de Québec, Québec, QC, Canada, (4)University of Western Ontario, London, ON, Canada, (5)Palo Alto Medical Foundation Research Institute, Palo Alto, CA, (6)Ottawa Health Research Institute, Ottawa, ON, Canada, (7)Universite Laval, Quebec, QC, Canada, (8)Université Laval, Québec, QC, Canada, (9)University of Ottawa, Ottawa, ON, Canada, (10)Maastricht University, Maastricht, Netherlands, (11)Cardiff University, Cardiff, United Kingdom
12
(DEC)
HEALTH CARE MANAGERS' PERSPECTIVE ON SHARED DECISION MAKING IN SPAIN
Lilisbeth Perestelo Perez, PhD1, Jeanette Perez-Ramos, MPsych2, Amado Rivero-Santana, PhD2, Marién Gonzalez-Lorenzo, PhD2, Roberto Martin-Fernandez2 and Pedro Serrano-Aguilar, PhD3, (1)Canary Islands Health Service. Ciber de Epidemiología y Salud Pública (CIBERESP), Tenerife, Spain, (2)Canary Islands Foundation for Health and Research (FUNCIS), Santa Cruz de Tenerife, Spain, (3)Canary Islands Health Service. Ciber de Epidemiología y Salud Pública (CIBERESP), Santa Cruz de Tenerife, Spain
13
(DEC)
DONATING YOUR BLOOD? ON THE ROLE OF ASSOCIATIONS, BELIEFS AND MOOD STATES IN DONOR DECISIONS
Marieke De Vries, PhD1, Rob W. Holland, PhD2, Berlinda Hermsen, PhD3 and Ad Van Knippenberg, PhD3, (1)Leiden University Medical Center, Leiden, Netherlands, (2)Radboud University Nijmegen, Nijmegen, Netherlands, (3)Behavioural Science Institute, Nijmegen, Netherlands
15
(DEC)
DOES IMPROVED NUMERACY MAKE THE GLASS HALF FULL? CANCER PATIENTS' OPTIMISM, NUMERACY, AND PERCEPTIONS OF THE COSTS OF TREATMENT
Yu-Ning Wong, MD, MSCE1, Kush Sachdeva, MD2, Olivia Hamilton3, Naa Eghan1, Brian Egleston1, Tammy Stump1, Melanie Pirollo2, J . Robert Beck, MD1 and Neal J. Meropol, MD4, (1)Fox Chase Cancer Center, Philadelphia, PA, (2)South Jersey Hospital, Vineland, NJ, (3)University of Pennsylvania, Philadelphia, PA, (4)University Hospitals Seidman Cancer Center, Case Comprehensive Cancer Center, Case Western Reserve University., Cleveland, OH
17
(DEC)
THE INFLUENCE OF POPULAR MEDIA ON PERCEPTIONS OF PERSONAL AND POPULATION RISK IN POSSIBLE DISEASE OUTBREAKS
Meredith E. Young, PhD1, Nicholas King, PhD1, Sam Harper, PhD1 and Karin Humphreys, PhD2, (1)McGill University, Montreal, QC, Canada, (2)McMaster University, Hamilton, ON, Canada
18
(DEC)
EVALUATION OF A DECISION AID FOR ANTIPSYCHOTIC MEDICATION
Lisa A. Mistler, MD, MS, University of Massachusetts, Grafton, MA, Laurie A. Curtis, Advocates for Human Potential Inc., Middlesex, VT and Irma H. Mahone, University of Virginia, Charlottesville, VA
19
(DEC)
REVISITING THE ONTOLOGY OF SHARED DECISION-MAKING IN PALLIATIVE CARE USING CRITICAL DISCURSIVE PSYCHOLOGY
Emmanuelle Belanger, MSc1, Charo Rodriguez, MD, PhD1, Danielle Groleau, PhD1, Mary Ellen Macdonald, PhD1, France Légaré, MD, PhD2 and Robert Marchand, MD3, (1)McGill University, Montreal, QC, Canada, (2)CHUQ Research Center-Hospital St-François d'Assise, Knowledge Transfer and Health Technology Assessment, Quebec, QC, Canada, (3)Université de Montréal, Montreal, QC, Canada
20
(DEC)
SHARED DECISION MAKING IN THE CARE OF PATIENTS WITH CHRONIC VISION IMPAIRMENT
Lori L. Grover, OD, Johns Hopkins University School of Medicine, Baltimore, MD, Kendall L. Krug, OD, Krug Optometry, Hays, KS and Kevin D. Frick, PhD, Johns Hopkins Bloomberg School of Public Health, Baltimore, MD
21
(DEC)
HOW DO BREAST IMAGING CENTERS COMMUNICATE RESULTS TO PATIENTS? RESULTS OF A NATIONAL SURVEY
Erin N. Marcus, M.D., M.P.H., Tulay Koru-Sengul, MHS, PhD, Feng Miao, M.S. and Lee Sanders, M.D., M.P.H., University of Miami Miller School of Medicine, Miami, FL
22
(DEC)
DECIDEO : INFORMED DECISION AND PARTICIPATION OF WOMEN TO THE NATIONAL SCREENING FOR BREAST CANCER : A QUALITATIVE OVERVIEW
Aurélie Bourmaud, MD1, Mathieu Oriol, MD2, Véronique Regnier, PhD.1, Nora Moumjid, PhD3, Patricia Soler, MD4 and Franck Chauvin, MD, PhD1, (1)Cancerology Institute of Loire and Jean Monnet University, Saint Etienne, France, (2)Institut de Cancérologie de la Loire, Saint Priest en Jarez, France, (3)Gresac - Umr 5823 Cnrs, Lyon, France, (4)ADEMAS 69, Lyon, France
23
(ESP)
PREDICTION MODEL FOR CAESAREAN SECTION RISK IN WOMEN WITH GESTATIONAL HYPERTENSION OR PREECLAMPSIA AT TERM
Karin van der Tuuk, M.D.1, Mariëlle van Pampus, M.D., Ph.D.1, Corine Koopmans, M.D., Ph.D.1, Jan Aarnoudse, M.D., Ph.D.1, Paul van den Berg, M.D., Ph.D.1, Ben W.J. Mol, PhD, MD2 and Henk Groen, M.D., Ph.D.1, (1)University of Groningen, Groningen, Netherlands, (2)Academic Medical Centre, Amsterdam, Netherlands
25
(ESP)
DISEASE BURDEN OF CHRONIC HEPATITIS B AMONG IMMIGRANTS IN CANADA
William W. L. Wong, Ph.D.1, Gloria Woo, PhD2, Jenny Heathcote, MD1 and Murray D. Krahn, MD, MSc1, (1)University of Toronto, Toronto, ON, Canada, (2)Faculty of Pharmacy, University of Toronto, Toronto, ON, Canada
26
(ESP)
CANTRANCE: FROM CANCER COMPARATIVE EFFECTIVENESS STUDIES TO DISEASE-SPECIFIC MORTALITY
Jeanette K. Birnbaum, MPH, University of Washington, Seattle, WA, Jeffrey Katcher, Fred Hutchinson Cancer Research Institute, Seattle, WA and Ruth Etzioni, PhD, Fred Hutchinson Cancer Research Center/ University of Washington, Seattle, WA
27
(ESP)
DOSE-RESPONSE RELATIONSHIP BETWEEN HOSPITAL SURGICAL VOLUME AND PATIENT SAFETY
Tina Hernandez-Boussard, PhD, MPH1, Kathryn M. McDonald, MM2 and John M. Morton, MD, MPH2, (1)Stanford University, Palo Alto, CA, (2)Stanford University, Stanford, CA
28
(ESP)
DEVELOPMENT OF A COMPUTER-ADAPTIVE INSTRUMENT TO MEASURE DISABILITY IN OLDER ADULTS
Christine M. McDonough, PhD, PT1, Ilona Kopits, MD, MPH2, Peng Sheng Ni, M.D., M.P.H.1, Tian Feng, MS1 and Alan M. Jette, Ph.D., P.T.1, (1)Boston University School of Public Health, Boston, MA, (2)Boston University Medical Center, Boston, MA
29
(ESP)
OBESITY AND MORTALITY IN PERSONS WITH AND WITHOUT OBESITY-RELATED DISEASES: USING DATA FROM NATIONAL HEALTH AND NUTRITION EXAMINATION SURVEY III
Su-Hsin Chang, PhD1, Lisa M. Pollack, MPT, MA2 and Graham A. Colditz, MD, DrPH1, (1)Division of Public Health Sciences, Washington University School of Medicine, St. Louis, MO, (2)Washington University in St. Louis, St. Louis, MO
31
(ESP)
FACTORS ASSOCIATED WITH THE CHOICE OF BIOLOGIC DISEASE MODIFYING ANTI-RHEUMATIC DRUGS AMONG RHEUMATOID ARTHRITIS PATIENTS IN CALIFORNIA MEDICAID
Li-Hao Chu, MPH1, Aniket A. Kawatkar, PhD, MS1 and Michael B. Nichol, PhD2, (1)Kaiser Permanente Southern California, Pasadena, CA, (2)University of Southern California, Los Angeles, CA
32
(ESP)
A DECISION SUPPORT TOOL FOR CATEGORIZING PATIENT ACUITY AT EMERGENCY DEPARTMENT
Yan Sun, PhD1, Bee Hoon Heng, MBBS, MSc(Public, Health)2, Swee Eng Choo, BSc, (Nursing)3, Che Kheng Ooi, MBBS, MSc(HSR)3 and Seow Yian Tay, MBBS, MSc(Medical, Informatics)3, (1)National Healthcare Group, Singapore, Singapore, (2)National Healthcare group, Singapore, Singapore, (3)Tan Tock Seng Hospital, Singapore, Singapore
33
(ESP)
EVALUATING A PROPOSED SWOG TRIAL OF BREAST CANCER TUMOR MARKERS: A VALUE OF RESEARCH AND BIOBANK ANALYSIS
Rahber Thariani, PhD1, Josh J. Carlson, PhD1, Lotte Steuten, PhD2, Lynn Henry, MD, PhD3, Julie Gralow, MD1, Scott Ramsey, MD, PhD4, Anirban Basu, PhD1 and David L. Veenstra, PharmD, PhD1, (1)University of Washington, Seattle, WA, (2)University of Twente, AE Enschede, Netherlands, (3)University of Michigan, Ann Arbor, MI, (4)Fred Hutchinson Cancer Research Center/ University of Washington, Seattle, WA
35
(ESP)
BUDGETARY IMPACT OF ADDING ROFLUMILAST TO MANAGED CARE FORMULARY IN THE TREATMENT OF CHRONIC OBSTRUCTIVE PULMONARY DISEASE
Shawn X. Sun, PhD1, Vladimir Zah, PhD(c)2 and Steven I. Blum, MBA1, (1)Forest Research Institute, Jersey City, NJ, (2)ZRx Outcomes Research Inc, Toronto, ON, Canada
37
(ESP)
ROBUSTNESS OF COST-EFFECTIVENESS ESTIMATES FOR CINACALCET IN SECONDARY HYPERPARATHYROIDISM BASED ON THE ADVANCE TRIAL
Rob Boer, PhD1, Anjana Lalla, MS1 and Vasily Belozeroff, PhD, MSc2, (1)Cerner LifeSciences, Beverly Hills, CA, (2)Amgen, Inc., Thousand Oaks, CA
38
(ESP)
USING DATA FROM SYSTEMATIC REVIEWS OR MULTIPLE SOURCES IN DECISION ANALYSES IMPACTS CONCLUSIONS
Rahul Mhaskar, PhD1, Helen Georgiev, MPH2, Hesborn Wao, PhD2, Ambuj Kumar, MD, MPH3 and Benjamin Djulbegovic, MD, PhD4, (1)University of South Florida,, Tampa, FL, (2)University of South Florida, Tampa, FL, (3)Center for Evidence Based Medicine, University of South Florids, Tampa, FL, (4)University of South Florida & H. Lee Moffitt Cancer Center & Research Institute, Tampa, FL
39
(ESP)
ASSESSING THE BROADER BENEFITS OF VACCINATION TO INFORM NATIONAL PRIORITY SETTING
Mark Jit, PhD1, Rohan Deogaonkar, BSc2, Inge van der Putten, BSc3, Silvia Evers, PhD3 and Raymond Hutubessy, PhD4, (1)Health Protection Agency, London, United Kingdom, (2)University of Birmingham, Birmingham, United Kingdom, (3)Maastricht University, Maastricht, Netherlands, (4)World Health Organization, Geneva, Switzerland
40
(ESP)
SYSTEMATIC REVIEW OF THE ECONOMIC AND EPIDEMIOLOGICAL BURDEN OF BLEEDING-RELATED COMPLICATIONS IN INDIA
Jonathan T. Tan, Ph.D1, Lachlan B. Standfield1, Jayashree Mapari2 and Laurent Metz, MD, MBA, MS3, (1)Health Technology Analysts Pty Ltd, Sydney, Australia, (2)Johnson & Johnson, Pune, India, (3)Johnson & Johnson, Singapore, Singapore
41
(ESP)
PRICE TRANSPARENCY: AN INNOVATIVE MEANS OF CONTROLLING MEDICAL EXPENDITURES?
Jennifer Schneider Chafen, M.D., M.S.1, Anastasia Toles, M.D., MPH2, Cathie Markow, MBA, RN2, Maeve O'Meara2 and Dena M. Bravata, MD, MS1, (1)Stanford University, Stanford, CA, (2)Castlight Health, San Francisco, CA
42
(ESP)
COST-EFFECTIVENESS OF MEDICARE PART D PLANS IN SCHIZOPHRENIA
Kenneth J. Smith, MD, MS, Seo Hyon Baik, PhD, Charles F. Reynolds, MD, Bruce L. Rollman, MD, MPH, Lei Zhou, MS and Yuting Zhang, PhD, University of Pittsburgh, Pittsburgh, PA
43
(ESP)
ADOPTION DECISIONS FOR NEW RADIOTHERAPY TECHNOLOGY FOR BREAST CANCER
Heather Taffet Gold, PhD1, Kimberly Pitrelli, MA1, Mary Katherine Hayes, MD2 and Madhuvanti Murphy, DrPH2, (1)New York University School of Medicine, New York, NY, (2)Weill Cornell Medical College, New York, NY
45
(ESP)
PATIENT-REPORTED PSORIASIS DISEASE FLARING AND IMPACT OF FLARE FREQUENCY ON HUMANISTIC OUTCOMES
Chureen T. Carter1, Silas Martin1, Marco DiBonaventura2, Kathy Annunziata2 and Deborah Freedman2, (1)Centocor Ortho Biotech Services, LLC, Horsham, PA, (2)Kantar Health, New York, NY
46
(ESP)
COST OF THERAPIES TO INDUCE REMISSION IN PATIENTS WITH WEGENER'S GRANULOMATOSIS
Awa Ndir, MPH1, Christian Pagnoux, MD, MPH2, Alfred Mahr, MD, PhD3, Loïc Guillevin, MD, Ph, D2 and Gwenaelle Vidal-Trecan, MD, PhD4, (1)Paris Descartes, Paris, France, (2)Université Paris Descartes - Faculté de médecine - AP-HP- Groupe hospitalier Cochin, Paris, France, (3)Faculty of Medicine, Paris, France, (4)Université Paris Descartes, Faculté de médecine, AP-HP, Paris, France
47
(ESP)
TRENDS IN THE USE OF INDIRECT COMPARISONS AND NETWORK META-ANALYSIS – EXPERIENCE FROM DRUG SUBMISSIONS FOR REIMBURSEMENT IN CANADA
Chris G. Cameron, BSc, EngDip, MSc, Canadian Agency for Drugs and Technologies in Health, Ottawa, ON, Canada and Karen M. Lee, MA, Canadian Agency for Drugs and Technologies in Health (CADTH), Ottawa, ON, Canada
48
(ESP)
EVALUATION OF CANCER INCIDENCE IN AUSTRIA AND TREATMENT PATHWAY IDENTIFICATION IN INTRAMURAL AND EXTRAMURAL HEALTH CARE BASED ON LONGITUDINAL ACCOUNTING DATA
Günther Zauner1, Patrick Einzinger2, Niki Popper1, Gottfried Endel3 and Felix Breitenecker2, (1)Dwh Simulation Services, Vienna, Austria, (2)Vienna University of Technology, Vienna, Austria, (3)Main Association of Austrian Social Security Institutions, Vienna, Austria
49
(ESP)
IMPACT OF NONCOMPLIANCE WITH DIABETES CARE GUIDELINES ON EMERGENCY ROOM VISITS AND HOSPITALIZATIONS IN A CALIFORNIA MEDICAID TYPE 2 DIABETES MELLITUS POPULATION
Michael B. Nichol, PhD1, Joanne Wu, MD, MS1, Julie L. Priest, MSPH2 and C. Ron Cantrell, Ph.D.2, (1)University of Southern California, Los Angeles, CA, (2)GlaxoSmithKline, Research Triangle Park, NC
51
(ESP)
PERCEPTIONS AND REALITIES OF FOOD FORTIFICATION IN PREVENTING ANEMIA
Nune Truzyan, DVM, MPH, Byron Crape, MSPH, PhD, Varduhi Petrosyan, MS, PhD and Ruzanna Grigoryan, MD, MPH, American University of Armenia, Yerevan, Armenia
53
(ESP)
VARIATION AMONG US STATES IN INPATIENT COST OF DIABETES-RELATED LOWER EXTREMITY AMPUTATION: IS THERE A REGIONAL PATTERN?
Sheldon X. Kong, Ph.D.1, Larry Radican, Ph.D.1 and Hongjun Yin, Ph.D.2, (1)Merck & Company, Inc., Whitehoue Station, NJ, (2)Long Island University, Brooklyn, NY
55
(ESP)
COMPARATIVE EFFECTIVENESS OF ANTIARRHYTHMIC DRUG THERAPY IN ATRIAL FIBRILLATION: FOCUS ON CARDIOVASCULAR HOSPITALIZATION AND MORTALITY OUTCOMES
Matthew Solomon, MD, Ph.D., Stanford University, Stanford, CA, Darius Lakdawalla, Ph.D., University of Southern California, Los Angeles, CA, Mintu Turakhia, MD, MAS, Stanford University School of Medicine, Stanford, CA, Mehul Jhaveri, PharmD, MPH, sanofi-aventis U.S., Bridgewater, NJ, Pamela Davis, MD, sanofi-aventis US, Bridgewater, NJ and Lily Bradley, MBA, Precision Health Economics, Santa Monica, CA
56
(ESP)
SURVIVAL-BASED QUALITY OF LIFE ASSESSMENTS
Walton Sumner, MD, Washington University, St. Louis, MO, Steven Kymes, Ph.D., Washington University School of Medicine, Saint Louis, MO, Jinzhong Xu, PhD, American Board of Family Medicine, Lexington, KY and Michael Hagen, MD, University of Kentucky, Lexington, KY
57
(ESP)
CAN DECISION TREE ANALYSIS BE USED TO IDENTIFY THE OPTIMAL EVENT PATHWAY TO REACH AN ACCURATE DIAGNOSIS? THE MAZE OF CARE STUDY IN OVARIAN CANCER
Lisa M. Hess, PhD, MA, MS, BA1, Michael W. Method, MD, MPH, MBA2, Frederick B. Stehman, MD1, Tess D. Weathers, MPH1, Paridha Gupta, MPH1 and Jeanne M. Schilder, MD1, (1)Indiana University School of Medicine, Indianapolis, IN, (2)Northern Indiana Cancer Research Consortium, South Bend, IN
